Search results for: 'path development'

09 Nov 2020  |  Global  |  Market Research

Technology Development Strategy Driving Waymo’s Innovative Business Models, 2020

Waymo’s In-house Technological Innovations and Strategic Partnerships Will Continue to Upend the Traditional Automotive Industry

Infographics

×

Key Issues Addressed

By the beginning of this decade, the term 'autonomous vehicles' had become familiar to the layman. Since the global COVID-19 pandemic, the automotive industry has been in a state of dichotomy. There is a clear realization that past predictions of launching fully autonomous vehicles by 2020 will not materialize; however, collective milestones in the...

11 Aug 2025  |  Global  |  Market Research

Advanced Wound Care Industry Driving Transformational Growth by Developing Digital Wound Management Solutions, Global, 2024–2030

Advanced Wound Care Industry is Experiencing Transformational Growth Due to the Development of Digital Wound Management Solutions

Infographics

×

The advanced wound care management industry is rapidly evolving with the emergence of sensor-based wearables, handheld wound scanners, disposable NPWT devices, AI-powered tools, digital wound assessment devices, and bioengineered skin substitutes. Advanced dressings—such as silicone and antimicrobial types—are also gaining traction, increasingly re...

10 May 2023  |  Global  |  Market Research

Growth Opportunities in the Biologics Contract Development and Manufacturing Organization Sector

Value Chain Expansion to Support Next generation Biologics Drives Future Growth Potential

Infographics

×

This research service provides an overview of the global biologics contract development and manufacturing organization (bio-CDMO) market and a 6-year market revenue forecast (2023 to 2028). The geographic scope covers three key regions, namely North America (NA); Europe; and Asia-Pacific (APAC). The report offers a detailed segment analysis of...

The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...

This research service encompasses a comprehensive analysis of RNA therapy industry from the following perspectives: • Industry Drivers and Challenges • Technology Snapshot and Trends • Clinical Pipeline Analysis • Overview of the IP Landscape • Innovator Profiles • Future Roadmap The RNA therapy platforms covered include: • Splice-Switching Oligon...

13 Sep 2021  |  North America  |  Market Research

Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities

Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential

Infographics

×

This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of p...

CDMOs are third-party vendors that offer outsourced development and manufacturing services for pharmaceutical drugs. In the small molecule manufacturing sector, CDMOs provide expert development and manufacturing services and are now an essential part of the pharmaceutical industry's value chain. The growing incidence of chronic diseases propels t...

The business environment in Developed Asia (Japan, South Korea, and Singapore) continues to be uncertain despite coordinated policy efforts and government stimuli to foster economic revival. The next few months are going to crucial for the region, as countries try to overcome the pandemic. This macroeconomic outlook for Developed Asia until 2026 w...

The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...